$0.00010
0.0000999900.00%
At close: -
Comments
Loading...
Fusion Pharm Analyst Ratings and Price Targets | OTC:FSPM | Benzinga
Fusion Pharm Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Fusion Pharm Corp from these most-recent analyst ratings.
Analyst Ratings for Fusion Pharm
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Fusion Pharm (FSPM) stock?
There is no price target for Fusion Pharm
What is the most recent analyst rating for Fusion Pharm (FSPM)?
There is no analyst for Fusion Pharm
When was the last upgrade for Fusion Pharm (FSPM)?
There is no last upgrade for Fusion Pharm
When was the last downgrade for Fusion Pharm (FSPM)?
There is no last downgrade for Fusion Pharm.
When is the next analyst rating going to be posted or updated for Fusion Pharm (FSPM)?
There is no next analyst rating for Fusion Pharm.
Is the Analyst Rating Fusion Pharm (FSPM) correct?
There is no next analyst rating for Fusion Pharm.
Browse analyst ratings and price targets on all stocks.
